From April 1, 2023 to June 30, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on January 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.91 CNY | +0.41% | -1.21% | -11.21% |
1st Jan change | Capi. | |
---|---|---|
-11.21% | 478M | |
+21.52% | 44.11B | |
+23.03% | 22.71B | |
+18.22% | 15.15B | |
+12.84% | 13.56B | |
+60.18% | 12.7B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.63B |
- Stock Market
- Equities
- 603669 Stock
- News Lionco Pharmaceutical Group Co.,Ltd.
- Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on January 31, 2023.